147 related articles for article (PubMed ID: 19075038)
1. Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats.
Samuelson E; Hedberg C; Nilsson S; Behboudi A
Endocr Relat Cancer; 2009 Mar; 16(1):99-111. PubMed ID: 19075038
[TBL] [Abstract][Full Text] [Related]
2. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
3. Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
Willner J; Wurz K; Allison KH; Galic V; Garcia RL; Goff BA; Swisher EM
Hum Pathol; 2007 Apr; 38(4):607-13. PubMed ID: 17258789
[TBL] [Abstract][Full Text] [Related]
4. Pathology of Endometrial Carcinoma.
Lax SF
Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
[TBL] [Abstract][Full Text] [Related]
5. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
Lax SF
Virchows Arch; 2004 Mar; 444(3):213-23. PubMed ID: 14747944
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations.
Konopka B; Janiec-Jankowska A; Czapczak D; Paszko Z; Bidziński M; Olszewski W; Goluda C
J Cancer Res Clin Oncol; 2007 Jun; 133(6):361-71. PubMed ID: 17219201
[TBL] [Abstract][Full Text] [Related]
8. Molecular approaches for classifying endometrial carcinoma.
Piulats JM; Guerra E; Gil-Martín M; Roman-Canal B; Gatius S; Sanz-Pamplona R; Velasco A; Vidal A; Matias-Guiu X
Gynecol Oncol; 2017 Apr; 145(1):200-207. PubMed ID: 28040204
[TBL] [Abstract][Full Text] [Related]
9. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract][Full Text] [Related]
10. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma.
Yoo SH; Park BH; Choi J; Yoo J; Lee SW; Kim YM; Kim KR
Mod Pathol; 2012 Nov; 25(11):1496-507. PubMed ID: 22766790
[TBL] [Abstract][Full Text] [Related]
11. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
Lax SF
Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of endometrial carcinoma.
Matias-Guiu X; Prat J
Histopathology; 2013 Jan; 62(1):111-23. PubMed ID: 23240673
[TBL] [Abstract][Full Text] [Related]
13. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
Bae HS; Kim H; Young Kwon S; Kim KR; Song JY; Kim I
Int J Gynecol Pathol; 2015 Jan; 34(1):74-84. PubMed ID: 25473756
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of endometrial hyperplasia and carcinoma.
Matias-Guiu X; Catasus L; Bussaglia E; Lagarda H; Garcia A; Pons C; Muñoz J; Argüelles R; Machin P; Prat J
Hum Pathol; 2001 Jun; 32(6):569-77. PubMed ID: 11431710
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma.
Boulanger E; Marchio A; Hong SS; Pineau P
Haematologica; 2009 Aug; 94(8):1170-4. PubMed ID: 19608668
[TBL] [Abstract][Full Text] [Related]
16. Recurrent chromosome 10 aberrations and Tp53 mutations in rat endometrial adenocarcinomas.
Nordlander C; Samuelson E; Klinga-Levan K; Behboudi A
Adv Exp Med Biol; 2008; 617():519-25. PubMed ID: 18497077
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
[TBL] [Abstract][Full Text] [Related]
18. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
19. Three cases of rare salivary gland tumours: a molecular study of TP53, CDKN2A/ARF, RAS, BRAF, PTEN, MAPK2 and EGFR genes.
Falbo V; Floridia G; Censi F; Marra M; Foschini MP; Taruscio D
Oncol Rep; 2011 Jul; 26(1):3-11. PubMed ID: 21503581
[TBL] [Abstract][Full Text] [Related]
20. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
